Update Magazine Archives - Page 3 of 25 - Food and Drug Law Institute (FDLI)

FDA Law and the Psychedelic Renaissance
Gallery
FDA Law and the Psychedelic Renaissance

Publications, Update Magazine, Update Spring 2024

FDA Law and the Psychedelic Renaissance

Update Magazine | Spring 2024

FDA Law and the Psychedelic Renaissanceadmin2024-03-11T09:59:22-04:00

Letter to the Editor: FDA Citizen Petition Seeks Historical Reckoning to Require the Labeling of Gluten on All Food Packages in the United States
Gallery
Letter to the Editor: FDA Citizen Petition Seeks Historical Reckoning to Require the Labeling of Gluten on All Food Packages in the United States

Publications, Update Magazine, Update Spring 2024

Letter to the Editor: FDA Citizen Petition Seeks Historical Reckoning to Require the Labeling of Gluten on All Food Packages in the United States

Update Magazine | Spring 2024

Letter to the Editor: FDA Citizen Petition Seeks Historical Reckoning to Require the Labeling of Gluten on All Food Packages in the United Statesadmin2024-04-01T09:46:22-04:00

Chevron Deference on the Brink: Small Fish May Mean Big Changes For FDA
Gallery
Chevron Deference on the Brink: Small Fish May Mean Big Changes For FDA

Publications, Update Magazine, Update Spring 2024

Chevron Deference on the Brink: Small Fish May Mean Big Changes For FDA

Update Magazine | Spring 2024

Chevron Deference on the Brink: Small Fish May Mean Big Changes For FDAadmin2024-02-23T10:29:50-05:00

Leqembi and the Accelerated Approval Pathway
Gallery
Leqembi and the Accelerated Approval Pathway

Publications, Update Magazine, Update Spring 2024

Leqembi and the Accelerated Approval Pathway

Update Magazine | Spring 2024

Leqembi and the Accelerated Approval Pathwayadmin2024-01-10T16:08:44-05:00

The Curious Case of Aspartame: How the Same Evidence Can Yield Seemingly Different Conclusions
Gallery
The Curious Case of Aspartame: How the Same Evidence Can Yield Seemingly Different Conclusions

Publications, Update Magazine, Update Spring 2024

The Curious Case of Aspartame: How the Same Evidence Can Yield Seemingly Different Conclusions

Update Magazine | Spring 2024

The Curious Case of Aspartame: How the Same Evidence Can Yield Seemingly Different Conclusionsadmin2024-01-10T16:11:37-05:00

Tech Support: FDA’s Evolving Regulatory Plan for Drug- and Device-Enabling Software
Gallery
Tech Support: FDA’s Evolving Regulatory Plan for Drug- and Device-Enabling Software

Publications, Update Magazine, Update Magazine Homepage, Update Winter 2023

Tech Support: FDA’s Evolving Regulatory Plan for Drug- and Device-Enabling Software

Update Magazine | Winter 2023

Tech Support: FDA’s Evolving Regulatory Plan for Drug- and Device-Enabling Softwareadmin2023-12-18T10:43:47-05:00

Risk Sharing Agreements in Brazil
Gallery
Risk Sharing Agreements in Brazil

Publications, Update Magazine, Update Winter 2023

Risk Sharing Agreements in Brazil

Update Magazine | Winter 2023

Risk Sharing Agreements in Braziladmin2023-12-18T10:43:24-05:00

Implementing MoCRA: FDA Releases New Draft Guidances on Insanitary Conditions for Tattoo Ink and Cosmetic Product Registration & Listing
Gallery
Implementing MoCRA: FDA Releases New Draft Guidances on Insanitary Conditions for Tattoo Ink and Cosmetic Product Registration & Listing

Publications, Update Magazine, Update Winter 2023

Implementing MoCRA: FDA Releases New Draft Guidances on Insanitary Conditions for Tattoo Ink and Cosmetic Product Registration & Listing

Update Magazine | Winter 2023

Implementing MoCRA: FDA Releases New Draft Guidances on Insanitary Conditions for Tattoo Ink and Cosmetic Product Registration & Listingadmin2023-11-21T14:25:00-05:00